Abiopharma

Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development

Aurora Spine Corporation Announces First Quarter FY26 Financial Results

Report of the subsidiary Ayalon: Examination of the possibility of issuing deferred capital notes Tier 1 - update regarding an institutional tender

Amber International Holding Limited Reports First Quarter 2026 Unaudited Financial Results

The companys financial results for the First Quarter 2026 were published abroad.

Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD

Ingredion announces strategic partnership with Sanstar Limited expanding access to pharma and food ingredient markets in India

Veeva Quality Cloud Advances Manufacturing Operations for Kindeva

908 Devices Inc. - 908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference

Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference